# A Safety Study of LY3372689 Given By Mouth to Healthy Participants

> **NCT03819270** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3372689
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03819270
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-05
- **Primary completion:** 2019-06-23
- **Final completion:** 2019-06-24
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03819270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03819270, "A Safety Study of LY3372689 Given By Mouth to Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03819270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*